Adamas: East Bay drug maker's potential sale brings lawsuits, job cuts
Nearly half of the drug maker's employees will lose their jobs in the potential $450 million deal.
Read full article »
CEO
Adamas is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of neurological diseases.
Read more